MARKET EYE-Pharma stocks fall on speculation over pricing policy

Thu Nov 22, 2012 2:47pm IST

Related Topics

Stocks

   

* Shares in Indian drugmakers fall on speculation the
government's final decision on the pricing policy for the sector
might be more disruptive than expected.
* Local media reports suggest a panel of ministers has agreed to
settle on a market-based pricing mechanism, as expected, but
capping drug prices at a simple average price of brands as
opposed to the initial proposal of using a weighted average. link.reuters.com/jur24t
* The proposal, if finalised, would be "incrementally negative"
for the sector, but the impact would vary from company to
company, Nomura says in a note on Thursday.
* The new proposal is likely to be more negative for Dr Reddy's
, Glenmark and Cadila Healthcare,
Nomura says. 
* Cipla falls 0.1 percent, while Ranbaxy Laboratories
 is down 0.9 percent. 
* Dr Reddy's Laboratories is flat, Glenmark Pharmaceuticals is
up 3.9 percent and Cadila gains 2.2 percent.

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net/kaustubh.kulkarni@thoms
onreuters.com /; kaustubh.kulkarni.reuters.com@reuters.net)
FILED UNDER:

Reuters Showcase

FMC-SEBI Merger

FMC-SEBI Merger

Regulatory shakeup could revive commodities markets   Full Article 

Market Eye

Market Eye

Sensex, Nifty end higher after bumpy budget-day trading  Full Article 

Tax Incentives

Tax Incentives

Budget woos foreign investors  Full Article 

Excise Duty

Excise Duty

Cigarette makers fall after budget hikes excise duty  Full Article 

Welcoming the Budget

Welcoming the Budget

India Inc cheers corporate tax cut, simpler rules  Full Article 

Gold Price

Gold Price

Gold prices to rise after budget keeps import duty high  Full Article 

Fuel Prices

Fuel Prices

IOC to raise diesel, petrol prices from Sunday  Full Article 

Moody's on Budget

Moody's on Budget

Budget "credit neutral" from a ratings perspective - Moody's   Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage